Ferring Pharmaceuticals launches Nocdurna in US to treat nocturia
Ferring Pharmaceuticals has announced the launch of Nocdurna (desmopressin acetate) in the United States, marking a significant advancement in the treatment of nocturia caused by ... Read More
FDA approves Serenity Pharmaceuticals’ Noctiva for nocturnal polyuria
Serenity Pharmaceuticals has received U.S. Food and Drug Administration (FDA) approval for Noctiva (desmopressin acetate), a nasal spray developed to treat nocturnal polyuria syndrome in ... Read More